# Population pharmacokinetic‐pharmacodynamic analyses of amyloid positron emission tomography and plasma biomarkers for lecanemab in subjects with early Alzheimer's disease

Article · Seiichi Hayato, Osamu Takenaka, Sree Harsha Sreerama Reddy, Ishani Savant Landry, Larisa Reyderman, Akihiko Koyama, Chad J. Swanson, Sanae Yasuda, Ziad Hussein

- Archive id: doi:10.1002/psp4.12862
- Published: 2022-09-27
- Venue: CPT Pharmacometrics & Systems Pharmacology
- DOI: https://doi.org/10.1002/psp4.12862
- PMID: 36165093
- Citations: 41
- Source URL: https://doi.org/10.1002/psp4.12862
- PDF: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/psp4.12862
- Provenance: openalex

_Abstract not reproduced: its license does not permit redistribution. See the source URL._

Topics: [Alzheimer's, Parkinson's & Neurodegeneration](https://space-kitty.com/topics/neurodegeneration)

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.